Summit Trail Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$871K Buy
+18,072
New +$843K 0.01% 988
2025
Q4
Sell
-4,933
Closed -$233K 1368
2025
Q3
$233K Buy
4,933
+199
+4% +$9.6K ﹤0.01% 1261
2025
Q2
$229K Buy
4,734
+124
+3% +$6.34K ﹤0.01% 1021
2025
Q1
$256K Buy
+4,610
New +$250K 0.01% 347
2024
Q4
Sell
-4,066
Closed -$234K 708
2024
Q3
$234K Buy
+4,066
New +$220K 0.01% 632
2018
Q3
Sell
-783
Closed -$31K 421
2018
Q2
$31K Sell
783
-9,251
-92% -$364K 0.01% 350
2018
Q1
$242K Buy
10,034
+1,959
+24% +$81.5K 0.04% 326
2017
Q4
$356K Buy
+8,075
New +$372K 0.05% 280

Other funds holding SNY

Summit Trail Advisors's SNY Position: Q1 2026 in Review

Summit Trail Advisors opened a new position in Sanofi (SNY) in Q1 2026: 18,072 shares worth $871K. The stake represents 0.01% of the portfolio and ranks #988 among its holdings. This is a return to the name: Summit Trail Advisors previously reported a position in SNY as recently as Q3 2025.

Summit Trail Advisors first reported a position in SNY in Q4 2017 and has held it in 8 quarters since. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Summit Trail Advisors held 18,072 shares of Sanofi worth $871K as of Q1 2026.
  • Sanofi was a new Summit Trail Advisors position in Q1 2026.
  • Sanofi made up 0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #988 holding.
  • Summit Trail Advisors first reported a position in Sanofi in Q4 2017 and has held it in 8 quarters since.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.